Swiss pharma giant Roche agrees $7.1 billion deal to buy Telavant Holdings

1 year ago

Swiss health care company Roche on Monday announced it would acquire Telavant Holdings in a $7.1 billion transaction. 

More Stories

Why our brains are wired to ignore the climate crisis | All Hail

27 mins ago

Pakistan preparing major offensive against Balochistan separatists

27 mins ago

Will the House ethics panel release report on Gaetz misconduct allegations?

27 mins ago

Leave a Reply

Your email address will not be published. Required fields are marked *

You may have missed

COP29: Africa’s negotiators urge world leaders to triple Adaptation Funds

27 mins ago

Nigeria’s population may surge to 450 million by 2050- Experts

27 mins ago

Institute conducts first human genome sequencing in Nigeria

27 mins ago

Philanthropist donates 25-year-old crocodile to UNILORIN Zoo

27 mins ago

Billam-Smith could go straight into a WBC title fight after Ramirez loss

27 mins ago